Eli Lilly & Co (LLY): Dividends Per Share
$6.23
Year ended 2025-12-31
+15.2%
3-year compound annual growth
+15.2%
5-year compound annual growth
| Period ended | Dividends Per Share | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $6.23 | +15.4% | 2026-02-12, From 2025-01-01 |
| 2024-12-31 | $5.40 | +15.1% | 2026-02-12, From 2024-01-01 |
| 2023-12-31 | $4.69 | +15.2% | 2026-02-12, From 2023-01-01 |
| 2022-12-31 | $4.07 | +15.3% | 2025-02-19, From 2022-01-01 |
| 2021-12-31 | $3.53 | +15.0% | 2024-02-21, From 2021-01-01 |
| 2020-12-31 | $3.07 | +14.6% | 2023-02-22, From 2020-01-01 |
| 2019-12-31 | $2.68 | +15.0% | 2022-02-23, From 2019-01-01 |
| 2018-12-31 | $2.33 | +9.9% | 2021-02-17, From 2018-01-01 |
| 2017-12-31 | $2.12 | +3.4% | 2020-02-19, From 2017-01-01 |
| 2016-12-31 | $2.05 | n/a | 2019-02-19, From 2016-01-01 |
| No annual figure between 2011-12-31 and 2016-12-31. | |||
| 2011-12-31 | $1.96 | 0.0% | 2012-02-24, From 2011-01-01 |
| 2010-12-31 | $1.96 | 0.0% | 2012-02-24, From 2010-01-01 |
| 2009-12-31 | $1.96 | +3.2% | 2012-02-24, From 2009-01-01 |
| 2008-12-31 | $1.90 | n/a | 2011-02-22, From 2008-01-01 |
Dividends Per Share at similar companies
| Company | Year ended | Dividends Per Share | Change YoY |
|---|---|---|---|
| Eli Lilly & Co (LLY) | 2025-12-31 | $6.23 | +15.4% |
| Merck & Co., Inc. (MRK) | 2025-12-31 | $3.28 | +5.1% |
| Pfizer Inc (PFE) | 2025-12-31 | $1.72 | +1.8% |
| AbbVie Inc. (ABBV) | 2025-12-31 | $6.65 | +5.7% |
| Bristol Myers Squibb Co (BMY) | 2025-12-31 | $2.49 | +2.9% |
| Johnson & Johnson (JNJ) | 2025-12-28 | $5.14 | +4.7% |
| Abbott Laboratories (ABT) | 2025-12-31 | $2.40 | +7.1% |
| Viatris Inc (VTRS) | 2025-12-31 | $0.48 | 0.0% |
| Zoetis Inc. (ZTS) | 2025-12-31 | $2.03 | +13.0% |
Compare LLY, MRK, PFE, ABBV side by side · Screen every company in Pharmaceutical Preparations ↗